CellTrend diagnostic test

The CellTrend Diagnostic Test is a commercial ME/CFS diagnostic immunoassay created by CellTrend, a German biotechnology company, and Professor Doctor Carmen Scheibenbogen. Cell-Trend bases its test on the theory that a subset of 20-30% of all patients suffering from ME/CFS have developed elevated levels of three auto-antibodies, i.e., auto-antibodies against the b2-adrenergic receptor, auto-antibodies against the muscarinic cholinergic receptor 3 (M3) and auto-antibodies against the muscarinic cholinergic receptor 4 (M4). The CellTrend Diagnostic Test immunoassay is a biochemical test that measures the presence of these three auto-antibodies.

Notable studies

 * 2016, Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome (Full Text)

Learn more

 * CellTrend Diagnostic Test webpage